Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname

Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname

ABSTRACT Convalescent plasma is a promising therapy for coronavirus disease 2019 (COVID-19), but its efficacy in intensive care unit (ICU) patients in low- and middle-income country settings such as Suriname is unknown. Bedside plasma separation using the HemoClear device made convalescent plasma th...

Full description

Bibliographic Details
Main Authors: R. Bihariesingh-Sanchit, R. Bansie, N. Ramdhani, R. Mangroo, D. Bustamente, E. Diaz, C. Fung A Foek, I. Thakoer, S. Vreden, Z. Choudhry, A. B. van ‘t Wout, D. A. Diavatopoulos, A. P. Nierich
Format: Article
Language:English
Published: American Society for Microbiology 2023-04-01
Series:mBio
Subjects:
convalescent plasma
COVID-19
HemoClear
ICU
mortality
SARS-CoV-2
Online Access:https://journals.asm.org/doi/10.1128/mbio.03379-22

Internet

https://journals.asm.org/doi/10.1128/mbio.03379-22

Similar Items